Randomized crossover study to examine the necessity of an injection-to-meal interval in patientswith type 2 diabetes and human insulin

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1865-1869

  Müller, Nicolle ^a   Frank, Thomas ^b   Kloos, Christof ^a   Lehmann, Thomas ^a   Wolf, Gunter ^a   Müller, Ulrich Alfons ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Practice for General Medicine and Diabetology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN;

AGED; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; EVENING DOSAGE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION TO MEAL INTERVAL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 84886003009     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1694     Document Type: Article

References (24)

1. Statistisches Bundesamt,Robert-Koch-Institut: Gesundheitsberichterstattung des Bundes: Germany [Internet], 2006. Available from https://www.gbebund.de/gbe10/owards.prc-show-pdf?p-id=9965&p-sprache= d&p-uid=gast&páid=11536177&p-lfd- nr=1. Accessed 28 March 2012
2. Hansen B, Altenhofen L, HaßW, Blaschy S, Kretschmann J. Report of the Disease Management Programmes 2007 in North Rhine: breast cancer, diabetes mellitus type 2, coronary artery disease, asthma, and COPD [Internet], 2008. KV North Rhine. Available from http://www.kvno. de/downloads/quali/qualbe-dmp08. pdf. Accessed 28 March 2012
3. Galloway JA, Spradlin CT, Nelson RL, Wentworth SM, Davidson JA, Swarner JL. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care 1981;4:366-376
4. Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982; 5:77-91.
5. Müller N, Kloos C, Frank T, Ristow M, Wolf G,Müller UA. Prevalence of injectionmeal interval usage and its association with variables of metabolic control in patients with type 1 and type 2 diabetes. Diabet Med 2011;28:223-226
6. Overmann H, Heinemann L. Injectionmeal interval: recommendations of diabetologists and how patients handle it. Diabetes Res Clin Pract 1999;43:137-142
7. Ahmad ABE, Badgandi M, Home PD. Interval between insulin injection and meal in relation to glycated haemoglobin. Pract Diabetes Int 2001;18:51-56
8. Davidson JK, Fineberg SE, De Meyts P, Fineberg NS, Galloway JA. Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin. Diabetes Care 1992;15:702-704
9. Kinmonth AL, Baum JD. Timing of prebreakfast insulin injection and postprandial metabolic control in diabetic children. BMJ 1980;280:604-606
10. Witt MF,White NH, Santiago JV. Roles of site an timing of the morning insulin injection in type 1 diabetes. J Pediatr1983;103:528-533
11. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6:374-377
12. Lean ME, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J (Clin Res Ed) 1985; 290:105-108
13. Bolli GB. Clinical strategies for controlling peaks and valleys: type 1 diabetes. Int J Clin Pract Suppl 2002;129:65-74
14. Kautzky-Willer A. Are "designer" insulins the "best" insulins?Wien KlinWochenschr2005;117:571-575 [in German]
15. Brunton S. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens. Diabetes Technol Ther 2008;10:247-256
16. Müller UA, Femerling M, Reinauer KM, et al.; ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany (Abstract). Diabetes Care 1999;22(Suppl. 2):B29-B34
17. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8:79-91
18. Bradley C. The diabetes treatment satisfaction questionnaire:DTSQ. In Handbook of Psychology and Diabetes: A Guide to Psychological Measurements in Diabetes Research and Practice. Bradley C, Ed. Chur, Switzerland, Harwood Academic Publishers, 1994
19. Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care 1999;22:530-532
20. Scheen AJ, Letiexhe MR, Lefèbvre PJ. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme. Diabetes Metab 1999;25:157-162
21. Reise K, Hartung V, Lehmann T, et al. Frequency of severe and nonsevere hypoglycaemia and difficulties at workplace in patients with insulin-treated diabetes mellitus (Abstract). Diabetologia 2011;54 (Suppl. 1):654
22. Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro comparedwith NPH insulin plus unmodified human insulin in individuals with type 1 diabetes. Diabetes Care 2008;31:1112-1117
23. Gale EAM; The UK Trial Group. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diabet Med 2000;17:209-214
24. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients with diabetesmellitus. In The Cochrane Library. Issue 1. Chichester, U.K., John Wiley & Sons Ltd., 2010